mRNA Vaccines And Therapeutics

Curia’s expertise in molecular biology, protein production, enzymes, nucleosides, and lipids forms the backbone of our mRNA solution, offering high-quality constructs and accelerated delivery through in-house research and analysis. Our end-to-end capabilities cover plasmid DNA production, enzyme and nucleoside manufacturing, and drug substance development, with reliable plasmid production for mRNA drug substances at our California and Massachusetts sites.

We also offer cGMP-compliant first-in-human clinical-scale manufacturing and analytical testing. With a proven track record in developing specialized lipids for mRNA applications, we manufacture lipids at metric-ton scale and provide advanced formulation capabilities, including liposome and lipid nanoparticle expertise. Our aseptic sterile fill-finish capabilities ensure reliable clinical and commercial manufacturing of mRNA injectable dosage products.